SELLAS Life Sciences (SLS) Current Leases (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Current Leases for 9 consecutive years, with $576000.0 as the latest value for Q3 2024.
- On a quarterly basis, Current Leases rose 23.61% to $576000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $576000.0, a 23.61% increase, with the full-year FY2023 number at $446000.0, up 19.89% from a year prior.
- Current Leases was $576000.0 for Q3 2024 at SELLAS Life Sciences, up from $531000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $576000.0 in Q3 2024 to a low of $100000.0 in Q2 2020.
- A 5-year average of $318105.3 and a median of $341000.0 in 2022 define the central range for Current Leases.
- Peak YoY movement for Current Leases: plummeted 72.38% in 2020, then soared 87.88% in 2022.
- SELLAS Life Sciences' Current Leases stood at $166000.0 in 2020, then rose by 19.28% to $198000.0 in 2021, then skyrocketed by 87.88% to $372000.0 in 2022, then rose by 19.89% to $446000.0 in 2023, then rose by 29.15% to $576000.0 in 2024.
- Per Business Quant, the three most recent readings for SLS's Current Leases are $576000.0 (Q3 2024), $531000.0 (Q2 2024), and $488000.0 (Q1 2024).